Literature DB >> 2469701

Aberrant phenotypes in peripheral T cell lymphomas.

N Hastrup1, E Ralfkiaer, G Pallesen.   

Abstract

Seventy six peripheral T cell lymphomas were examined immunohistologically to test their reactivity with a panel of monoclonal antibodies against 11 T cell associated antigens (CD1-8, CD27, UCHL1, and the T cell antigen receptor). Sixty two (82%) lymphomas showed aberrant phenotypes, and four main categories were distinguished as follows: (i) lack of one or several pan-T cell antigens (49, 64% of the cases); (ii) loss of both the CD4 and CD8 antigens (11, 15% of the cases); (iii) coexpression of the CD4 and CD8 antigens (13, 17% of the cases); and (iv) expression of the CD1 antigen (eight, 11% of the cases). No correlation was seen between the occurrence of aberrant phenotypes and the histological subtype. It is concluded that the demonstration of an aberrant phenotype is a valuable supplement to histological assessment in the diagnosis of peripheral T cell lymphomas. It is recommended that the panel of monoclonal antibodies against T cell differentiation antigens should be fairly large, as apparently any antigen may be lost in the process of malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469701      PMCID: PMC1141912          DOI: 10.1136/jcp.42.4.398

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Peripheral T-cell lymphoma: aggressive disease with heterogeneous immunotypes.

Authors:  T M Grogan; K Fielder; C Rangel; C J Jolley; D P Wirt; M J Hicks; T P Miller; R Brooks; B Greenberg; S Jones
Journal:  Am J Clin Pathol       Date:  1985-03       Impact factor: 2.493

2.  Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues.

Authors:  A J Norton; A D Ramsay; S H Smith; P C Beverley; P G Isaacson
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

3.  Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.

Authors:  L M Weiss; G S Crabtree; R V Rouse; R A Warnke
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

4.  Morphological and immunohistochemical characteristics of T-cell malignant lymphomas in the west of Scotland.

Authors:  A S Jack; F D Lee
Journal:  Histopathology       Date:  1986-03       Impact factor: 5.087

5.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

6.  The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides.

Authors:  G S Wood; J S Burke; S Horning; R S Doggett; R Levy; R A Warnke
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

7.  Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses.

Authors:  E Ralfkiaer; G L Wantzin; D Y Mason; K Hou-Jensen; H Stein; K Thomsen
Journal:  Am J Clin Pathol       Date:  1985-11       Impact factor: 2.493

8.  The phenotypic diversity of peripheral T-cell lymphomas: the Southeastern Cancer Study Group experience.

Authors:  M J Borowitz; T A Reichert; R K Brynes; J B Cousar; C C Whitcomb; R D Collins; J D Crissman; G E Byrne
Journal:  Hum Pathol       Date:  1986-06       Impact factor: 3.466

9.  Immunopathology of cutaneous T-cell lymphomas.

Authors:  K Nasu; J Said; E Vonderheid; J Olerud; D Sako; M Kadin
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

10.  The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.

Authors:  R S Doggett; G S Wood; S Horning; R Levy; R F Dorfman; J Bindl; R A Warnke
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

View more
  10 in total

1.  Aberrant phenotypes in Kikuchi's disease.

Authors:  Xue-Jing Wei; Xiao-Ge Zhou; Jian-Lan Xie; Xiao-Dan Zheng; Yuan-Yuan Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen.

Authors:  D Y Mason; J Cordell; M Brown; G Pallesen; E Ralfkiaer; J Rothbard; M Crumpton; K C Gatter
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

3.  Computer assisted selection and assessment of antibodies in the diagnosis of lymphomas.

Authors:  P J Harkin; S A Kelly; A S Jack
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

4.  Expression of monoclonal antibody HML-1-defined alpha E beta 7 integrin in cutaneous T cell lymphoma.

Authors:  I Simonitsch; B Volc-Platzer; I Mosberger; T Radaszkiewicz
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

5.  Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Maura Rossi; Katia Basso; Simonetta Zupo; Philip Went; Ulf Klein; Pier Luigi Zinzani; Michele Baccarani; Riccardo Dalla Favera; Stefano A Pileri
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

Review 6.  Hodgkin's lymphoma: the pathologist's viewpoint.

Authors:  S A Pileri; S Ascani; L Leoncini; E Sabattini; P L Zinzani; P P Piccaluga; A Pileri; M Giunti; B Falini; G B Bolis; H Stein
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

7.  New monoclonal antibodies to the T cell antigens CD4 and CD8. Production and characterization in formalin-fixed paraffin-embedded tissue.

Authors:  S L Williamson; M Steward; I Milton; A Parr; N H Piggott; A S Krajewski; B Angus; C H Horne
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Co-expression of CD4 and CD8 associated with elevated interleukin-4 in a cord T cell line derived by co-cultivating normal cord leukocytes and an HTLV-II-producing simian leukocyte cell line (Si-IIA).

Authors:  K Hayashi; N Ohara; K Fujiwara; H Aoki; H J Jeon; K Takahashi; N Tomita; K Miyamoto; T Akagi
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy.

Authors:  LaBaron T Washington; Yang O Huh; Linda C Powers; Madeleine Duvic; Dan Jones
Journal:  BMC Clin Pathol       Date:  2002-12-10

Review 10.  Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.

Authors:  Sara Yumeen; Michael Girardi
Journal:  Yale J Biol Med       Date:  2020-03-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.